Trial
NCT05712694
Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Polaris Group
Collaborators
—
Condition
Soft Tissue Sarcoma
Intervention
ADI PEG20
Why stopped
Lack of Efficacy, no safety concern.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-25